World’s First 100% Recombinant Salmon PDRN
Developed using proprietary biosynthesis technology, RJMPDRN® REC redefines the PDRN standard with sustainability, high purity, and exceptional safety.
Key Advantages:
Precision Engineering – Our patented biosynthesis technology delivers 100% sequence-accurate functional polynucleotides. Both fragment length and sequence structure are fully controllable, significantly enhancing molecular fragment concentration and transdermal efficiency.
Validated Bioactivity – Functionally verified, RJMPDRN® REC promotes fibroblast migration, enhances Type I/III collagen production, and significantly reduces key inflammatory mediators such as TNF-α and IL-6, providing dual benefits of skin regeneration and anti-inflammation.
Green & Sustainable – Free from animal-derived components, this solution eliminates reliance on uncontrolled biological supply chains and aligns with global regulatory trends.
Enhanced Quality – Eliminates risks associated with animal-derived pathogens, offering high purity, excellent batch-to-batch consistency, stable efficacy, and scalable, reliable supply.
This sustainable biotechnology innovation sets a new benchmark in PDRN applications, perfectly combining scientific rigor with proven biological efficacy. We also offer plant-derived and salmon-derived PDRN, and you are warmly welcome to learn more about them.
